SYNERPHYSICS

Dillon Capital Strategies (DCS) is a boutique advisory firm specializing in strategy, business development and business analytics in the biotech, pharma and medical products industry. DCS's full suite of services provide clients with VISION, to develop PLANNING, and take ACTION. DCS focuses on the business side of drug, device and diagnostic development and partnering. DCS serves pharma, biotech and investment firms, large and small, worldwide in their efforts to find, assess, value and secure partnering deals across all therapeutic areas. DCS also provides a customizable suite of services to supplement executive management needs at smaller firms. DCS's packaged and custom-built decision-support tools underpin its ability to provide actionable and uncommon insight to clients on both the "buy" and "sell" side of transactions. DCS is built on nearly three decades of pharma and biotech executive management and corporate planning experience, including early development of five companies,..

Also known as: Dillon Capital Strategies (DCS), Synerphysics, Inc.

Primary location: Texas United States